415 related articles for article (PubMed ID: 22748826)
1. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
Sharma HS; Castellani RJ; Smith MA; Sharma A
Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
3. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
Zhu D; Su Y; Fu B; Xu H
Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
[TBL] [Abstract][Full Text] [Related]
4. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
6. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
Banks WA
Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
[TBL] [Abstract][Full Text] [Related]
10. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
11. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
[TBL] [Abstract][Full Text] [Related]
12. [Role of the blood-brain barrier in Alzheimer's disease].
Gosselet F; Candela P; Cecchelli R; Fenart L
Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
[TBL] [Abstract][Full Text] [Related]
13. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
14. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
[TBL] [Abstract][Full Text] [Related]
15. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
16. Is RAGE still a therapeutic target for Alzheimer's disease?
Deane RJ
Future Med Chem; 2012 May; 4(7):915-25. PubMed ID: 22571615
[TBL] [Abstract][Full Text] [Related]
17. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
18. [Blood-brain barrier and Alzheimer's disease].
Kuwahara H; Nishida Y; Yokota T
Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
[TBL] [Abstract][Full Text] [Related]
19. Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.
Mehta DC; Short JL; Hilmer SN; Nicolazzo JA
Pharm Res; 2015 Mar; 32(3):819-39. PubMed ID: 25319097
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
